Radhakrishnan Maha 4
4 · Entrada Therapeutics, Inc. · Filed Jun 3, 2025
Insider Transaction Report
Form 4
Radhakrishnan Maha
Director
Transactions
- Award
Stock Option (Right to Buy)
2025-06-01+38,000→ 38,000 totalExercise: $7.60From: 2025-06-01Exp: 2035-06-01→ Common Stock (38,000 underlying)
Footnotes (1)
- [F1]The stock option shall vest in equal monthly installments over three years from the date of grant, subject to the reporting person's continuous service through the applicable vesting date.